Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADC Therapeutics SA

3.17
+0.08002.59%
Volume:692.40K
Turnover:2.15M
Market Cap:356.62M
PE:-2.01
High:3.19
Open:3.10
Low:3.04
Close:3.09
52wk High:3.97
52wk Low:1.05
Shares:112.50M
Float Shares:92.24M
Volume Ratio:1.01
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5758
EPS(LYR):-1.6246
ROE:-705.53%
ROA:-22.99%
PB:-1.79
PE(LYR):-1.95

Loading ...

ADC Therapeutics to sell 13M shares at $3.53 in private placement

TIPRANKS
·
Jun 12

Press Release: ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

Dow Jones
·
Jun 12

ADC Therapeutics Announces Promising LOTIS-7 Trial Results for ZYNLONTA® & Glofitamab Combo in r/r DLBCL Patients

Reuters
·
Jun 12

ADC Therapeutics SA Conducted Annual General Meeting

Reuters
·
Jun 06

ADC Therapeutics falls -4.5%

TIPRANKS
·
Jun 04

ADC Therapeutics SA Announces New Inducement Plan with Stock Options for New Employees

Reuters
·
Jun 03

ADC Therapeutics SA Unveils Corporate Presentation Highlighting ZYNLONTA Expansion and Next-Gen ADC Developments

Reuters
·
May 22

ADC Therapeutics Price Target Maintained With a $8.00/Share by RBC Capital

Dow Jones
·
May 15

Analysts’ Top Healthcare Picks: ADC Therapeutics (ADCT), Verve Therapeutics (VERV)

TIPRANKS
·
May 15

ADC Therapeutics SA to Participate in RBC Capital Markets Global Healthcare Conference

Reuters
·
May 15

ADC Therapeutics SA reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

ADC Therapeutics Reports Stable Q1 2025 Product Revenues at $17.4M, License Revenues Surge to $5.6M

Reuters
·
May 14

Press Release: ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

Dow Jones
·
May 14

Pyxis Oncology Inc. to Participate in RBC Capital Markets Global Healthcare Conference

Reuters
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

ADC Therapeutics SA expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 12

ADC Therapeutics SA expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 02

AC Immune (ACIU) Reports Q1 Loss, Lags Revenue Estimates

Zacks
·
Apr 30

Agenus (AGEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks
·
Apr 29

ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks
·
Apr 28